Halfmann PJ - Search Results

1

Characterization of the SARS-CoV-2 B.1.621 (Mu) variant.

Halfmann PJ, Kuroda M, Armbrust T, Theiler J, Balaram A, Moreno GK, Accola MA, Iwatsuki-Horimoto K, Valdez R, Stoneman E, Braun K, Yamayoshi S, Somsen E, Baczenas JJ, Mitamura K, Hagihara M, Adachi E, Koga M, McLaughlin M, Rehrauer W, Imai M, Yamamoto S, Tsutsumi T, Saito M, Friedrich TC, O'Connor SL, O'Connor DH, Gordon A, Korber B, Kawaoka Y. Halfmann PJ, et al. Sci Transl Med. 2022 Aug 10;14(657):eabm4908. doi: 10.1126/scitranslmed.abm4908. Epub 2022 Aug 10. Sci Transl Med. 2022. PMID: 35579540 Free PMC article.

2

Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses.

Hatta M, Gao P, Halfmann P, Kawaoka Y. Hatta M, et al. Science. 2001 Sep 7;293(5536):1840-2. doi: 10.1126/science.1062882. Science. 2001. PMID: 11546875

3

Human influenza a viral genes responsible for the restriction of its replication in duck intestine.

Hatta M, Halfmann P, Wells K, Kawaoka Y. Hatta M, et al. Virology. 2002 Apr 10;295(2):250-5. doi: 10.1006/viro.2002.1358. Virology. 2002. PMID: 12033783 Free article.

4

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, Theriault S, Suzuki H, Nishimura H, Mitamura K, Sugaya N, Usui T, Murata T, Maeda Y, Watanabe S, Suresh M, Suzuki T, Suzuki Y, Feldmann H, Kawaoka Y. Kobasa D, et al. Nature. 2004 Oct 7;431(7009):703-7. doi: 10.1038/nature02951. Nature. 2004. PMID: 15470432

5

Regions in Ebola virus VP24 that are important for nucleocapsid formation.

Noda T, Halfmann P, Sagara H, Kawaoka Y. Noda T, et al. J Infect Dis. 2007 Nov 15;196 Suppl 2:S247-50. doi: 10.1086/520596. J Infect Dis. 2007. PMID: 17940956

6

Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome.

Watanabe S, Noda T, Halfmann P, Jasenosky L, Kawaoka Y. Watanabe S, et al. J Infect Dis. 2007 Nov 15;196 Suppl 2:S284-90. doi: 10.1086/520582. J Infect Dis. 2007. PMID: 17940962

7

Generation of biologically contained Ebola viruses.

Halfmann P, Kim JH, Ebihara H, Noda T, Neumann G, Feldmann H, Kawaoka Y. Halfmann P, et al. Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1129-33. doi: 10.1073/pnas.0708057105. Epub 2008 Jan 22. Proc Natl Acad Sci U S A. 2008. PMID: 18212124 Free PMC article.

8

Replication-deficient ebolavirus as a vaccine candidate.

Halfmann P, Ebihara H, Marzi A, Hatta Y, Watanabe S, Suresh M, Neumann G, Feldmann H, Kawaoka Y. Halfmann P, et al. J Virol. 2009 Apr;83(8):3810-5. doi: 10.1128/JVI.00074-09. Epub 2009 Feb 11. J Virol. 2009. PMID: 19211761 Free PMC article.

9

Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.

Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G, Halfmann P, Kawaoka Y. Nanbo A, et al. PLoS Pathog. 2010 Sep 23;6(9):e1001121. doi: 10.1371/journal.ppat.1001121. PLoS Pathog. 2010. PMID: 20886108 Free PMC article.

10

Contribution of Sec61α to the life cycle of Ebola virus.

Iwasa A, Halfmann P, Noda T, Oyama M, Kozuka-Hata H, Watanabe S, Shimojima M, Watanabe T, Kawaoka Y. Iwasa A, et al. J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S919-26. doi: 10.1093/infdis/jir324. J Infect Dis. 2011. PMID: 21987770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters